Maria D. Moskey
Abbott (United Kingdom)(GB)Abbott Fund(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Synthesis and biological activity, Quinazolinone synthesis and applications, Angiogenesis and VEGF in Cancer, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Discovery ofN-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N‘-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor(2007)184 cited
- → Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors(2005)152 cited
- → Thienopyridine urea inhibitors of KDR kinase(2006)45 cited
- → Isoindolinone ureas: a novel class of KDR kinase inhibitors(2004)32 cited
- → 3-Amino-benzo[d]isoxazoles as Novel Multitargeted Inhibitors of Receptor Tyrosine Kinases(2008)31 cited
- → Identification of a selective thieno[2,3-c]pyridine inhibitor of COT kinase and TNF-α production(2009)27 cited
- → Discovery of thieno[2,3-c]pyridines as potent COT inhibitors(2008)25 cited
- → Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinases(2006)21 cited
- → Synthesis and biological evaluation of 5-substituted 1,4-dihydroindeno[1,2-c]pyrazoles as multitargeted receptor tyrosine kinase inhibitors(2007)11 cited